Generative AI

ABLi Therapeutics reports its drug risvodetinib is the first to lower toxic alpha-synuclein levels in a Phase 2 trial, heralding a new era for patients.

With its Felix AI assistant, Syncx is accelerating locums staffing with faster placements and risk assessment to combat a critical healthcare shortage.

As demand for data centers and electrification soars, nVent brings in veteran Mellinda Devese to transform its global supply chain and secure future growth.

With a new finance chair and a renewed pact with an activist investor, the off-price retailer is doubling down on its modernization and growth strategy.

Pakistan launches its ambitious national AI strategy, combining a $1B investment with a push for sovereign compute to reshape its economic future.

New research reveals how clinical trial design inflates the placebo effect, offering a key to solving the 90% failure rate for anxiety and depression drugs.

A new stamp-sized oral film could replace the dreaded epinephrine needle. Aquestive's Anaphylm shows promise, but faces regulatory and market hurdles.

A legacy financial educator pivots to digital assets with a hands-on course, but can it overcome the shadow of its predecessor's FTC lawsuit?

Digital Culture Group's new award celebrates executives blending cultural insight with data, setting a new standard for accountable growth in advertising.

As Europe's landmark MiCAR regulation takes hold, KuCoin EU expands its Vienna compliance team, signaling a strategic shift toward regulated growth.

Norsemont Mining's initial Phase 3 drilling at Choquelimpie reveals promising geology, but the annual Altiplano Winter forces a temporary halt.

Amid a global AI push, a new partnership aims to move beyond principles to provide practical, measurable AI governance for emerging economies.

Traini's Sentra collar promises to translate barks into emotions, but experts urge caution on AI accuracy, data privacy, and the future of pet care.

As AI floods the internet with synthetic identities, Humanity Protocol's new framework aims to restore trust by verifying facts without exposing your data.

UST's top partner award from TestMu AI highlights a new era of AI-driven testing, promising faster, more reliable software for global enterprises.

The iBuying giant reports faster sales and record margins for new home buys, signaling its turnaround plan may finally be taking hold.

Travere Therapeutics reports a profitable Q4 driven by its kidney drug FILSPARI, but a revenue miss and a critical FDA decision create a complex outlook.

The smart property leader surpasses a major revenue milestone, driven by AI-powered security and energy management, but a mixed 2026 forecast follows.

Five9 reports a record $1.1B year and a return to profitability, as its new CEO bets big on AI to reshape the customer experience market.

Lyft CFO Erin Brewer will address investors at the Bernstein TMT Forum, outlining the company's strategy for sustained profitability and future growth.